|
JPH11503619A
(ja)
*
|
1996-01-19 |
1999-03-30 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
スタフィロコッカス・アウレウスのメチオニル−ｔＲＮＡシンセターゼ
|
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
|
JP2003506011A
(ja)
*
|
1999-04-15 |
2003-02-18 |
ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア |
ソーターゼ遺伝子の同定
|
|
US7101692B2
(en)
*
|
1999-04-15 |
2006-09-05 |
The Regents Of The University Of California |
Identification of sortase gene
|
|
US7125698B2
(en)
*
|
1999-08-09 |
2006-10-24 |
Matthew Glenn |
Polynucleotides, materials incorporating them, and methods for using them
|
|
CA2386235A1
(en)
*
|
1999-10-04 |
2001-04-12 |
Merck & Co., Inc. |
Mray gene and enzyme of pseudomonas aeruginosa
|
|
US6861516B1
(en)
|
1999-10-04 |
2005-03-01 |
Merck & Co., Inc. |
MraY gene and enzyme of pseudomonas aeruginosa
|
|
US20020120408A1
(en)
*
|
2000-09-06 |
2002-08-29 |
Kreiswirth Barry N. |
System and method for tracking and controlling infections
|
|
US7349808B1
(en)
|
2000-09-06 |
2008-03-25 |
Egenomics, Inc. |
System and method for tracking and controlling infections
|
|
WO2002034771A2
(en)
|
2000-10-27 |
2002-05-02 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
|
US20020107368A1
(en)
*
|
2000-12-07 |
2002-08-08 |
Jing-Hui Tian |
Helicobacter proteins, gene sequences and uses thereof
|
|
DK1355918T5
(da)
|
2000-12-28 |
2012-02-20 |
Wyeth Llc |
Rekombinant beskyttelsesprotein af streptococcus pneumoniae
|
|
AT410798B
(de)
*
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
GB0107658D0
(en)
*
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
AU2002307448A1
(en)
*
|
2001-04-20 |
2002-11-05 |
President And Fellows Of Harvard College |
Methods and compositions for the modulation of biofilm formation
|
|
AU2002328215A1
(en)
*
|
2001-09-18 |
2003-04-01 |
Affinium Pharmaceuticals, Inc. |
Purified bacterial polypeptides involved in nucleic acid processing
|
|
AU2002328225A1
(en)
*
|
2001-09-21 |
2003-04-01 |
Affinium Pharmaceuticals, Inc. |
Bacterial polypeptides involved in protein processing
|
|
WO2003045985A2
(en)
*
|
2001-11-26 |
2003-06-05 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides involved in carbohydrate and coenzyme metabolism
|
|
AU2002331473A1
(en)
*
|
2001-09-25 |
2003-04-07 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides from pseudomonas aeruginosa
|
|
WO2003029407A2
(en)
*
|
2001-09-26 |
2003-04-10 |
Merck & Co., Inc. |
Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
|
|
EP1930420A1
(en)
*
|
2001-09-26 |
2008-06-11 |
Merck & Co., Inc. |
Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
|
|
US20040029129A1
(en)
*
|
2001-10-25 |
2004-02-12 |
Liangsu Wang |
Identification of essential genes in microorganisms
|
|
EP1456380B1
(en)
*
|
2001-11-02 |
2012-04-18 |
Giuliani International Limited |
Smad7 inhibitors for the treatment of cns diseases
|
|
RU2229513C2
(ru)
|
2001-11-23 |
2004-05-27 |
Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" |
Способ получения l-аминокислот, штамм escherichia coli - продуцент l-аминокислоты (варианты)
|
|
AU2002364771A1
(en)
*
|
2001-11-26 |
2003-06-10 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides involved in general metabolism as possible drug targets
|
|
TW200303919A
(en)
*
|
2001-12-05 |
2003-09-16 |
Hiroyuki Ohno |
Cytotoxic protein and the use
|
|
US20030170694A1
(en)
*
|
2001-12-21 |
2003-09-11 |
Daniel Wall |
Stabilized nucleic acids in gene and drug discovery and methods of use
|
|
WO2003066849A2
(en)
*
|
2002-02-04 |
2003-08-14 |
Affinium Pharmaceuticals, Inc. |
Novel purified polypeptides from staphylococcus aureus
|
|
US6946267B2
(en)
*
|
2002-03-13 |
2005-09-20 |
Dr. Chip Biotechnology Inc. |
Method for detecting Staphylococcus aureus
|
|
WO2003087353A2
(en)
*
|
2002-04-08 |
2003-10-23 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides involved in membrane biogenesis
|
|
US20090252756A1
(en)
*
|
2002-04-02 |
2009-10-08 |
Yaffa Mizrachi-Nebenzahl |
Protein-based streptococcus pneumoniae vaccines
|
|
US8691243B2
(en)
|
2002-04-02 |
2014-04-08 |
Ben-Gurion University Of The Negev Research And Development Authority |
Protein-based Streptococcus pneumoniae vaccine
|
|
AU2003213950A1
(en)
*
|
2002-04-08 |
2003-10-27 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism
|
|
AU2003218563A1
(en)
*
|
2002-04-09 |
2003-10-27 |
Affinium Pharmaceuticals, Inc. |
Enolase polypeptides and structures
|
|
AU2003218934A1
(en)
*
|
2002-04-17 |
2003-11-03 |
Affinium Pharmaceuticals, Inc. |
Purified (3r)-hydroxymyristoyl-(acyl-carrier-protein) dehydratase polypeptide from pseudomonas aeruginosa
|
|
AU2003229205A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Affinium Pharmaceuticals, Inc. |
Bacterial polypeptides involved in viability
|
|
WO2003102544A2
(en)
*
|
2002-05-31 |
2003-12-11 |
Cognosci, Inc. |
Assays for measuring matrix metalloproteinase activities
|
|
US20060035365A1
(en)
*
|
2002-07-17 |
2006-02-16 |
Hamelin Michael J |
Method for identifying cellular growth inhibitors
|
|
WO2004013167A2
(en)
*
|
2002-08-01 |
2004-02-12 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides from enterococcus faecalis
|
|
AU2003278714A1
(en)
*
|
2002-08-20 |
2004-03-11 |
Chiron Corporation |
Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes
|
|
US20070053924A1
(en)
*
|
2002-08-26 |
2007-03-08 |
Herve Tettelin |
Conserved and specific streptococcal genomes
|
|
AU2003280247A1
(en)
*
|
2002-11-05 |
2004-06-07 |
Affinium Pharmaceuticals, Inc. |
Essential novel bacterial polypeptides
|
|
FR2846668B1
(fr)
*
|
2002-11-05 |
2007-12-21 |
Univ Aix Marseille Ii |
Identification moleculaire des bacteries du genre streptococcus et genres apparentes
|
|
AU2003280250A1
(en)
*
|
2002-11-05 |
2004-06-07 |
Affinium Pharmaceuticals, Inc. |
Crystal structures of bacterial thymidylate kinases
|
|
WO2004058812A2
(en)
*
|
2002-12-26 |
2004-07-15 |
Affinium Pharmaceuticals, Inc. |
Ribose-phosphate pyrophosphokinase polypeptides and structures
|
|
WO2004081206A2
(en)
*
|
2003-03-12 |
2004-09-23 |
Affinium Pharmaceuticals, Inc. |
Novel polypeptides encoded by essential bacterial genes
|
|
AU2003287825A1
(en)
*
|
2002-12-31 |
2004-07-22 |
Affinium Pharmaceuticals, Inc. |
Crystal structures of nh3-dependent nad synthetases
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
US7618775B2
(en)
*
|
2003-04-17 |
2009-11-17 |
The Scripps Research Institute |
Expanding the eukaryotic genetic code
|
|
US20050026189A1
(en)
*
|
2003-05-29 |
2005-02-03 |
Liangsu Wang |
Microbial operons
|
|
JP4875490B2
(ja)
*
|
2003-07-31 |
2012-02-15 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
|
|
US8945589B2
(en)
*
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
|
EP1670505B1
(en)
|
2003-09-18 |
2012-11-14 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Dna promoters and anthrax vaccines
|
|
ATE520709T1
(de)
|
2003-09-19 |
2011-09-15 |
Epitopix Llc |
Campylobacter-polypeptide und verwendungsverfahren
|
|
US20050176033A1
(en)
*
|
2003-11-10 |
2005-08-11 |
Klyachko Elena V. |
Mutant phosphoribosylpyrophosphate synthetase and method for producing L-histidine
|
|
WO2005108626A2
(en)
*
|
2004-05-07 |
2005-11-17 |
Replidyne, Inc. |
Mutants of staphylococcal mrs and methods of use
|
|
JP2008507296A
(ja)
*
|
2004-07-26 |
2008-03-13 |
ナノスフェアー インコーポレイテッド |
混合培養物中でメチシリン耐性黄色ブドウ球菌とメチシリン感受性黄色ブドウ球菌とを区別する方法
|
|
EP1784211A4
(en)
|
2004-07-29 |
2010-06-30 |
Novartis Vaccines & Diagnostic |
IMMUNOGENIC COMPOSITIONS FOR GRAMPOSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE
|
|
US20060078952A1
(en)
*
|
2004-09-14 |
2006-04-13 |
Carine Robichon |
Method for identifying antimicrobial molecules which interfere with apolipoprotein N-acyltransferase activity
|
|
US20080095792A1
(en)
*
|
2004-09-17 |
2008-04-24 |
Anderson Annaliesa S |
Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus
|
|
CA2583803C
(en)
*
|
2004-10-08 |
2014-11-25 |
Giuliano Bensi |
Immunogenic and therapeutic compositions for streptococcus pyogenes
|
|
DE102004055508A1
(de)
*
|
2004-11-17 |
2006-06-01 |
Basf Ag |
Verfahren zur Herstellung optisch aktiver Alkohole
|
|
ES2589927T3
(es)
|
2005-01-21 |
2016-11-17 |
Merck Sharp & Dohme Corp. |
Polipéptidos para inducir una respuesta inmunitaria protectora contra Staphylococcus aureus
|
|
CN101142230A
(zh)
|
2005-01-21 |
2008-03-12 |
埃皮托皮克斯有限责任公司 |
耶尔森氏菌属物种的多肽及其使用方法
|
|
AU2006214534B2
(en)
|
2005-02-14 |
2012-07-19 |
Epitopix, Llc |
Polypeptides from Staphylococcus aureus and methods of use
|
|
GB0505949D0
(en)
|
2005-03-23 |
2005-04-27 |
Univ Sheffield |
Polypeptides
|
|
NZ591415A
(en)
*
|
2005-03-30 |
2012-10-26 |
Novartis Vaccines & Diagnostic |
Haemophilus influenzae type B
|
|
WO2007093848A2
(en)
*
|
2005-08-03 |
2007-08-23 |
Affinium Pharmaceuticals, Inc. |
Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori
|
|
US8945899B2
(en)
|
2007-12-20 |
2015-02-03 |
Butamax Advanced Biofuels Llc |
Ketol-acid reductoisomerase using NADH
|
|
US7960312B2
(en)
*
|
2005-11-10 |
2011-06-14 |
National University Of Corporation Hiroshima University |
Method and agent for immobilizing protein via protein bound to silicon oxide-containing substance
|
|
WO2007106536A2
(en)
|
2006-03-14 |
2007-09-20 |
Oregon Health & Science University |
Methods for producing an immune response to tuberculosis
|
|
ATE522541T1
(de)
*
|
2006-06-09 |
2011-09-15 |
Novartis Ag |
Bakterielle adhäsine konformere
|
|
EP2074231B1
(en)
*
|
2006-09-14 |
2010-06-16 |
Universitat De Girona |
A method for specific detection of salmonella spp
|
|
FR2906532B1
(fr)
*
|
2006-09-28 |
2008-12-12 |
Biomerieux Sa |
Nouvel oligonucleotide marque
|
|
WO2008044599A1
(fr)
*
|
2006-10-06 |
2008-04-17 |
Proteus Science Co., Ltd. |
Polypeptide ayant une activité de ciblage d'un intestin présentant une inflammation, et son utilisation
|
|
JP2010508276A
(ja)
*
|
2006-10-30 |
2010-03-18 |
ノバルティス アーゲー |
化膿連鎖球菌のための免疫原性組成物および治療組成物
|
|
BRPI0808600A2
(pt)
*
|
2007-04-18 |
2018-12-26 |
Du Pont |
"método para a conversão de acetolactato em dihidroxi-isovalerato, método para a produção de isobutanol, célula hospedeira recombinante e método para a identificação e isolameno de uma construção genética"
|
|
US8017337B2
(en)
|
2007-04-19 |
2011-09-13 |
Molecular Detection, Inc. |
Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
|
|
JP2010183841A
(ja)
*
|
2007-05-29 |
2010-08-26 |
Ajinomoto Co Inc |
Ｌ−アミノ酸の製造法
|
|
KR20100072228A
(ko)
|
2007-08-31 |
2010-06-30 |
유니버시티 오브 시카고 |
스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
|
|
US9181329B2
(en)
|
2007-08-31 |
2015-11-10 |
The University Of Chicago |
Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
|
|
MX2010002773A
(es)
|
2007-09-12 |
2010-03-31 |
Novartis Ag |
Antigenos mutantes de gas57 y anticuerpos de gas57.
|
|
BRPI0821748A2
(pt)
*
|
2007-12-19 |
2019-09-24 |
Basf Plant Science Gmbh |
método para produzir uma planta com rendimento aumentado, molécula isolada de ácido nucleico, construção de ácido nucleico, vetor, processo para produzir um polipeptídeo, polipeptídeo, anticorpo, núcleo de célula de planta, célula de planta, tecido de planta, material de propagação, semente, pólen, progênie, ou uma parte de planta, ou uma planta com rendimento aumento, processo para a indentificação de um composto, método para a produção de uma composição agrícola, composição, polipeptídeo ou molécula de ácido nucleico, uso dos ácidos nucléicos, e, método para a indentificação de uma planta com um rendimento aumentado
|
|
DK2235046T3
(da)
*
|
2007-12-21 |
2012-10-29 |
Novartis Ag |
Mutante former af streptolysin-O
|
|
FI20075976A0
(fi)
*
|
2007-12-31 |
2007-12-31 |
Finnzymes Oy |
Menetelmät ja oligonukleotidit utaretulehdusta aiheuttavien bakteerien osoittamiseksi
|
|
WO2009100215A2
(en)
|
2008-02-08 |
2009-08-13 |
Mayo Foundation For Medical Education And Research |
Detection of clostridium difficile
|
|
WO2009111337A1
(en)
|
2008-03-03 |
2009-09-11 |
Irm Llc |
Compounds and compositions as tlr activity modulators
|
|
US8758765B2
(en)
|
2008-07-29 |
2014-06-24 |
The University Of Chicago |
Compositions and methods related to Staphylococcal bacterium proteins
|
|
KR100975956B1
(ko)
*
|
2008-08-08 |
2010-08-13 |
주식회사 콤슨테크놀러지 |
살균기능을 가지는 장애인용 이동장치
|
|
US8637249B2
(en)
*
|
2008-11-14 |
2014-01-28 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of Campylobacter nucleic acid
|
|
JP2012509665A
(ja)
*
|
2008-11-26 |
2012-04-26 |
メルク・シャープ・エンド・ドーム・コーポレイション |
スタフィロコッカス・アウレウス（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に対する防御免疫応答を誘導するポリペプチド
|
|
CN105582524A
(zh)
*
|
2009-03-23 |
2016-05-18 |
埃皮托皮克斯有限责任公司 |
多肽和含有革兰氏阳性多肽的免疫组合物及使用方法
|
|
HUE026855T2
(en)
|
2009-04-03 |
2016-07-28 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
US9517263B2
(en)
|
2009-06-10 |
2016-12-13 |
Glaxosmithkline Biologicals Sa |
Benzonaphthyridine-containing vaccines
|
|
TWI445708B
(zh)
|
2009-09-02 |
2014-07-21 |
Irm Llc |
作為ｔｌｒ活性調節劑之化合物及組合物
|
|
EA026401B1
(ru)
|
2009-09-02 |
2017-04-28 |
Новартис Аг |
Иммуногенные композиции, содержащие модуляторы активности tlr
|
|
WO2011057148A1
(en)
|
2009-11-05 |
2011-05-12 |
Irm Llc |
Compounds and compositions as tlr-7 activity modulators
|
|
MX339146B
(es)
|
2009-12-15 |
2016-05-13 |
Novartis Ag |
Suspension homogenea de compuestos inmunopotenciadores y usos de los mismos.
|
|
MX341395B
(es)
|
2010-03-23 |
2016-08-18 |
Novartis Ag * |
Compuestos (lipopeptidos basados en cisteina) y composiciones como agonistas de tlr2 usados para el tratamiento de infecciones, inflamaciones, enfermedades respiratorias, etc.
|
|
KR101933226B1
(ko)
|
2010-05-05 |
2018-12-28 |
뉴욕 유니버시티 |
스타필로코커스 아우레우스 류코시딘, 치료 조성물 및 그것의 용도
|
|
SG186290A1
(en)
|
2010-07-02 |
2013-01-30 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
|
JP6048932B2
(ja)
*
|
2010-12-28 |
2016-12-21 |
国立大学法人広島大学 |
酸化ケイ素と窒化ケイ素とを識別するポリペプチドおよびその利用
|
|
MX347976B
(es)
|
2011-03-24 |
2017-05-22 |
Butamax(Tm) Advanced Biofuels Llc |
Celulas huesped y metodos para producir isobutanol.
|
|
WO2012136653A1
(en)
*
|
2011-04-08 |
2012-10-11 |
Novvac Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
GB201116767D0
(en)
|
2011-09-28 |
2011-11-09 |
St George S Hospital Medical School |
Treatment for mitrochondrial neurogastrointestinal encephalomyopathy
|
|
EP2773655A4
(en)
*
|
2011-10-31 |
2015-04-22 |
Merck Sharp & Dohme |
PROTECTION BASED ON STAPHYLOCOCCUS AUREUS SA2074 PROTEIN
|
|
DK2812434T3
(en)
|
2012-02-09 |
2018-07-16 |
Bavarian Nordic As |
AGONISTS AND ANTAGONISTS OF TOLL-LIKE RECEPTOR-13 (TLR-13)
|
|
US9181568B2
(en)
*
|
2012-04-23 |
2015-11-10 |
Exxonmobil Research And Engineering Company |
Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases
|
|
PL2844275T3
(pl)
|
2012-04-26 |
2021-03-08 |
University Of Chicago |
Koagulazy gronkowcowe stanowiące antygeny i sposoby ich zastosowania
|
|
WO2013176909A2
(en)
|
2012-05-11 |
2013-11-28 |
Butamax Advanced Biofuels Llc |
Ketol-acid reductoisomerase enzymes and methods of use
|
|
WO2014011645A1
(en)
|
2012-07-10 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Protective vaccine based on staphylococcus aureus sa2493 protein
|
|
KR20150056540A
(ko)
*
|
2012-09-19 |
2015-05-26 |
노파르티스 아게 |
백신으로서의 클로스트리듐 디피실 폴리펩티드
|
|
US9512408B2
(en)
|
2012-09-26 |
2016-12-06 |
Butamax Advanced Biofuels Llc |
Polypeptides with ketol-acid reductoisomerase activity
|
|
NZ707035A
(en)
|
2012-10-17 |
2018-11-30 |
Agronomique Inst Nat Rech |
Gene signatures of inflammatory disorders that relate to the liver
|
|
EP2950819B1
(en)
|
2013-02-01 |
2018-03-28 |
GlaxoSmithKline Biologicals SA |
Intradermal delivery of immunological compositions comprising toll-like receptor agonists
|
|
KR20150013092A
(ko)
*
|
2013-07-26 |
2015-02-04 |
삼성전자주식회사 |
숙신산 생산능이 향상된 박테리아 세포 및 이를 이용하여 숙신산을 생산하는 방법
|
|
CA2919383A1
(en)
|
2013-08-05 |
2015-02-12 |
Greenlight Biosciences, Inc. |
Engineered proteins with a protease cleavage site
|
|
US10100093B2
(en)
|
2013-12-31 |
2018-10-16 |
Epitopix Llc |
Polypeptides and immunizing compositions containing Burkholderia polypeptides and methods of use
|
|
US20170049848A1
(en)
*
|
2014-05-06 |
2017-02-23 |
Virginia Commonwealth University |
Target for Firmicutes and Related Bacteria: The PRP Protease
|
|
HRP20191671T1
(hr)
|
2014-05-09 |
2019-12-13 |
Immatics Biotechnologies Gmbh |
Nova imunoterapija za liječenje nekoliko tumora krvi, kao što je akutna mijeloidna leukemija (aml)
|
|
GB201408255D0
(en)
*
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
|
FR3024903A1
(fr)
|
2014-08-14 |
2016-02-19 |
Biomerieux Sa |
Procede de quantification d'au moins un groupe de microorganismes par spectrometrie de masse
|
|
TWI649331B
(zh)
*
|
2015-06-11 |
2019-02-01 |
國立中興大學 |
鮑氏不動桿菌（Ａｃｉｎｅｔｏｂａｃｔｅｒ ｂａｕｍａｎｎｉｉ）多胜肽抗原及其抗體以及編碼該抗原之核酸
|
|
CN108368500B
(zh)
|
2015-10-02 |
2023-05-26 |
犹他大学研究基金会 |
用于可调整核糖体翻译速度的组成物和使用方法
|
|
US10166280B2
(en)
|
2016-06-08 |
2019-01-01 |
Epitopix, Llc |
Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
|
|
KR102050870B1
(ko)
*
|
2017-04-06 |
2019-12-02 |
포항공과대학교 산학협력단 |
무항생제 플라스미드 유지 시스템에서 플라스미드 카피 수의 정량적 조절 방법
|
|
CN111867623B
(zh)
|
2018-02-12 |
2024-06-04 |
英尼穆内公司 |
Toll样受体配体
|
|
US12018327B2
(en)
|
2018-03-01 |
2024-06-25 |
The Regents Of The University Of California |
Methods and compositions relating to epoxide hydrolase genes
|
|
US12514914B2
(en)
|
2019-05-14 |
2026-01-06 |
The University Of Chicago |
Methods and compositions comprising Staphylococcus protein a (SpA) variants
|
|
CA3148183C
(en)
*
|
2019-08-28 |
2024-10-15 |
Inner Mongolia Eppen Biotech Co., Ltd. |
RECOMMENDED STRAIN BASED ON ESCHERICHIA COLI AND ITS CONSTRUCTION PROCESS AND APPLICATION
|
|
CA3153902A1
(en)
|
2019-10-16 |
2021-04-22 |
Pardis SABETI |
Engineered muscle targeting compositions
|
|
JP7471688B2
(ja)
*
|
2019-12-03 |
2024-04-22 |
中國醫藥大學 |
オリゴペプチド、検出キット及び医薬組成物
|
|
US20230287437A1
(en)
*
|
2020-06-05 |
2023-09-14 |
Modernatx, Inc. |
Bacterial strains for dna production
|
|
KR20230098825A
(ko)
|
2020-11-04 |
2023-07-04 |
엘리고 바이오사이언스 |
씨. 아크네스 개체군에게 dna 페이로드의 원위치 전달을 위한 파지-유래 입자
|
|
EP4399316A4
(en)
*
|
2021-09-08 |
2025-11-12 |
Broad Inst Inc |
MODIFIED FORMS FOR TARGETING THE CENTRAL NERVOUS SYSTEM AND MUSCLES
|
|
CN114032313B
(zh)
*
|
2021-11-18 |
2024-09-17 |
广东海洋大学 |
一种评估、检测和/预测耗牛的牛肉品质性状的方法
|
|
EP4516310A1
(en)
*
|
2022-04-28 |
2025-03-05 |
The University of Tokyo |
Bacteriolytic agent against enterococcus faecalis
|
|
EP4662323A2
(en)
*
|
2023-02-09 |
2025-12-17 |
Kate Therapeutics, Inc. |
Muscle targeted capsids
|